Key result
Increased left atrial stiffness predicts ~30% lower cardiac event-free survival in HFrEF, especially with diabetes.
Why the study?
The study aimed to investigate the relationship between DM and LA remodelling in HFrEF, and their combined impact on cardiac events.
Does increased left atrial stiffness and diabetes mellitus predict cardiac events in patients with HFrEF?
Cohort (n=136)
Does increased left atrial stiffness and diabetes mellitus predict cardiac events in patients with HFrEF?
Absolute Event Rate: 50% vs 80%
p-value: p=< .001
High left atrial stiffness, particularly when combined with diabetes, is a strong predictor of poor clinical outcomes in patients with HFrEF.
BACKGROUND: The aim of this study was to investigate the relationship between diabetes mellitus (DM) and left atrial (LA) remodelling in a group of patients with heart failure and reduced ejection fraction (HFrEF), and their combined impact on cardiac events (CE). METHODS: This study included 136 consecutive HFrEF patients (65 ± 11 years), 36 had DM, and 86 had increased LA stiffness (LASt). All patients underwent complete conventional and tissue Doppler echocardiographic measurements were made including LA volumes and function. LASt was calculated using the formula: LASt = E/e' ratio / PALS. RESULTS: At 55 ± 37 months follow-up, free survival from CE was 69% in patients without DM and 44.4% in those with DM (p < .0001). The CE free survival was lower in patients with increased LASt compared to normal LASt, (50 versus. 80%, p < .001), irrespective of the presence of DM (27 versus. 71%, p < .001).The best cut-off value of LASt for predicting CE in the group as a whole was ≥ 0.82% [81% sensitivity, 72% specificity and AUC 0.82 (p < .001)]. LASt ≥ 0.82% also predicted CE in no DM patients [78% sensitivity, 71% specificity and AUC 0.80 (p < .001)] and was a stronger predictor in DM patients [85% sensitivity, 71% specificity and AUC = 0.847 (p < .001)]. CONCLUSION: High LA stiffness is associated with poor clinical outcome in patients with HFrEF. Diabetes has an additional incremental value in determining clinical outcome in those patients.
No takes yet. Share an insight, caveat, or question.
Bytyçi et al. (2020) conducted a cohort in Heart failure and reduced ejection fraction (HFrEF) (n=136). Increased left atrial stiffness (LASt) vs. Normal left atrial stiffness was evaluated on Cardiac events (CE) free survival (p=< .001). Increased left atrial stiffness predicted lower cardiac event-free survival in HFrEF patients (50% vs 80%, p<0.001), with diabetes providing additional incremental prognostic value.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: